Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) | PA 18 868

Opportunity Information: Apply for PA 18 868

The National Institutes of Health (NIH) funding opportunity titled "Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)" (Funding Opportunity Number: PA-18-868; CFDA: 93.172) supports research projects that move beyond simply finding statistical links between DNA variants and traits. The core problem this program targets is that modern genomics has generated huge lists of variants connected to disease risk, protection, or other phenotypes through genome-wide association studies (GWAS) and clinical sequencing, yet in many cases researchers still cannot tell which specific variants are actually causal, what biological mechanisms they affect, or how those functional changes translate into disease. In clinical sequencing, this gap shows up as large numbers of "variants of uncertain significance" (VUS), which limits the usefulness of genetic test results in medical decision-making. This opportunity is designed to fund generalizable, broadly applicable approaches that can connect genetic variation to molecular or cellular function and ultimately to disease processes, with an emphasis on strategies that can improve how genetic information is interpreted and used clinically.

The scientific scope is centered on developing and validating methods, tools, and frameworks that can identify which variants in genomic elements are responsible for observed associations and clarify the functional consequences of those variants. In practical terms, the program is looking for projects that can establish clearer chains of evidence from variant to function to disease mechanism. That could include improved experimental strategies for interrogating variant effects, computational or statistical approaches that prioritize likely causal variants, integrative methods that combine different data types to infer function, or scalable pipelines to interpret variants encountered in clinical sequencing. The emphasis on "generalizable approaches" signals that the NIH is interested in solutions that can be applied across genes, variant classes, traits, or diseases, rather than one-off explanations limited to a single locus or a narrowly defined dataset.

The mechanism is an R01 research project grant, which typically supports investigator-initiated, hypothesis-driven or methodologically innovative work at a scale appropriate for multi-year research programs. The notice specifies "Clinical Trial Not Allowed," meaning the funded work should not include prospective assignment of human participants to interventions to evaluate health-related outcomes under the NIH clinical trial definition. That restriction still leaves room for many types of human genetics research, such as analyses of existing datasets, observational studies, work with de-identified samples, functional genomics in cell systems, animal models, or other experimental and computational approaches, as long as they do not constitute a clinical trial.

Eligibility is broad and includes many organizational types. Eligible applicants listed include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses) and small businesses; and other entities. The announcement also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) organizations. This broad eligibility reflects NIH interest in encouraging a wide research community to contribute solutions, including institutions serving underrepresented groups and international partners with relevant expertise or resources.

Administratively, the opportunity is categorized as discretionary funding and uses the grant funding instrument under the health funding activity category, with the sponsoring agency being the NIH. The source data provided lists an original closing date of 2021-07-05 and a creation date of 2018-07-23. The award ceiling and expected number of awards are not specified in the provided record, which often means applicants need to consult the full funding announcement and NIH program guidance for budget expectations, project period norms, and any institute- or center-specific preferences.

Overall, this grant opportunity is aimed at closing the translation gap between genetic association and actionable biology. It prioritizes research that can systematically determine which genetic variants matter, explain what they do in biological systems, connect those effects to disease pathways, and ultimately reduce uncertainty in clinical interpretation, particularly for variants that currently remain classified as VUS.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
• This funding opportunity was created on 2018-07-23.
• Applicants must submit their applications by 2021-07-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 868

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: